Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,729.48
(
0.45%
)
US TECH 100
24,164.80
(
0.62%
)
Dow Jones
47,098.72
(
0.32%
)
Brent Oil
100.49
(
2.22%
)
Bitcoin
74,675.81
(
-0.22%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Bio_pete

Send PM Follow Ignore
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Bio_pete

Re: DewDiligence post# 86162

Wednesday, 11/11/2009 6:34:32 PM

Wednesday, November 11, 2009 6:34:32 PM

Post# of 257251
Dew, if TEVA is using an injector for delivery of low volume Copaxone would this still be filed as a supplemental NDA? What time-line would the FDA follow for this type of review? One of the analysts asked this question on the call and management didn't deny an injector was being utilized in the study.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now